GET DAILY SIGNALSTranscat (TRNS) Delivers +18% Revenue Growth and Raises Full-Year Outlook
Key Takeaways
- Transcat reported second quarter fiscal 2027 revenue of $97.1 million, up 18% year over year and above analyst consensus estimates.
- Adjusted earnings per share (EPS) came in at $0.64, well ahead of consensus, reflecting strong profit flow-through.
- Service organic revenue growth accelerated to 16%, marking the company's 70th consecutive quarter of service revenue growth.
- Service gross margin expanded 220 basis points (bps) to 34.4%, while adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) rose 23% to $14.9 million.
- Management raised its full-year fiscal 2027 service organic revenue growth outlook to low double digits, up from high single digits.
- For more detail on the company's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for additional insights.
- Explore Trending AI Robots to see how AI-driven trading strategies are navigating the current market environment.
Putting These Results in Context
Transcat, Inc. (TRNS) provides accredited calibration services and distributes test and measurement equipment. The second-quarter fiscal 2027 results, for the period ended September 26, 2026, shed light on demand in regulated sectors including life sciences, aerospace and defense, and energy. With a significant portion of revenue tied to recurring calibration work, the quarter highlights pricing trends, margin performance, and customer retention. I’m watching service organic growth and gross margin expansion closely as indicators of the company’s ability to build profitability while pursuing acquisitions.
The Quarter’s Reported Numbers
Consolidated revenue reached $97.1 million, an 18% increase from the prior year and above the roughly $92 million consensus estimate. Service revenue climbed 23% to $64.8 million, with 16% organic growth, while distribution revenue advanced 10% to $32.3 million. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Consolidated gross profit rose 22% to $32.6 million, and gross margin improved 110 bps to 33.6%. Service gross margin widened 220 bps to 34.4%. Net income increased 90% year over year, and diluted EPS grew 79% to $0.25. Adjusted diluted EPS of $0.64 rose 46% and exceeded consensus, while adjusted EBITDA advanced 23% to $14.9 million at a 15.4% margin. Management lifted its fiscal 2027 full-year service organic revenue growth guidance to the low double digits from high single digits and reaffirmed expectations for further service gross margin expansion.
Market Reaction and Investor Sentiment
Shares of Transcat (TRNS) rose following the release, with early indications pointing to a gain of around 6%. The combination of faster organic service growth, margin expansion, and the raised outlook supported sentiment. The 70th straight quarter of service revenue growth underscored the strength of the recurring revenue model, while growth across geographies and end markets suggested the momentum is broad-based rather than concentrated in one area.
What to Watch Going Forward
Attention now turns to whether Transcat can maintain double-digit service organic growth and continue expanding margins. Management anticipates at least 100 bps of year-over-year service gross margin improvement in the second half of fiscal 2027, supported by Lean principles, mix optimization, and pricing. From what I see, acquisition activity will remain key, as evidenced by the August purchase of Southeastern Biomedical Associates, which broadened biomedical calibration reach in the southeastern United States. The higher-margin rental business should also continue aiding the distribution segment. Key items to monitor include new large customer wins, acquisition integration, and demand trends in regulated markets. Early productivity gains from AI initiatives were noted and could become more material over time. Investors should also track leverage, operating free cash flow, and distribution margins to assess overall execution.
Exploring AI-Powered Research Tools
I often turn to Tickeron’s AI Screener when evaluating names like Transcat alongside peers. The tool lets me apply filters for technical patterns, fundamentals, and performance metrics to surface comparable opportunities quickly. It has become a regular part of my workflow for identifying setups in the calibration and measurement sector without manual effort.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
TRNS in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 16, 2026
TRNS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 33 of 38 cases where TRNS's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where TRNS's RSI Oscillator exited the oversold zone, 21 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on TRNS as a result. In 64 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
The Moving Average Convergence Divergence (MACD) for TRNS just turned positive on October 27, 2026. Looking at past instances where TRNS's MACD turned positive, the stock continued to rise in 34 of 48 cases over the following month. The odds of a continued upward trend are 71%.
TRNS moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +3.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where TRNS advanced for three days, in 235 of 333 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 10-day moving average for TRNS crossed bearishly below the 50-day moving average on October 09, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 17 of 21 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 81%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRNS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 74%.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. TRNS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 84 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRNS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.717) is normal, around the industry mean (6.110). TRNS's P/E Ratio (237.622) is considerably higher than the industry average of (32.833). Projected Growth (PEG Ratio) (0.860) is also within normal values, averaging (1.946). Dividend Yield (0.000) settles around the average of (0.025) among similar stocks. P/S Ratio (2.257) is also within normal values, averaging (9.907).
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of electronic monitoring instruments used for measurement and calibration
Industry OfficeEquipmentSupplies
Advertisement